References
- Blyth WA, Hill TJ, Field HJ, Harbour DA. Reactivation of herpes simplex virus infection by ultraviolet light and possible involvement of prostaglandins. J Gen Virol.1976;33:547–550.
- Hill TJ, Blyth WA. An alternative theory of herpes-simplex recurrence and a possible role for prostaglandins. Lancet.1976;Feb 21:1(7956):397–399.
- Harbour DA, Blyth WA, Hill TJ. Prostaglandins enhance spread of herpes simplex virus in cell cultures. J Gen Virol.1978;41:87–95.
- Newton AA. Effect of cyclic nucleotides on the response of cells to infection by various herpesviruses. In: deThe G, Henle W, Rapp F, editors. Oncogenesis and Herpes VirusesIII. Lyon: I.A.R.C.; 1978:381–387.
- Newton AA. Inhibitors of prostaglandin synthesis as inhibitors of herpes simplex virus replication. Adv Oph-thalmol.1979;38:58–63.
- Newton AA. Prostaglandins and the replication of herpes simplex type 1. In: Shiota H, Cheng Y-C, Prusoff WH, editors. Herpesvirus. Clinical,Pharmacological and Basic Aspects.Amsterdam: Excerpta Medica; 1982:192–200.
- Trofatter KF Jr, Daniels CA. Effect of prostaglandins and cyclic adenosine 3',5'-monophosphate modulators on herpes simplex virus growth and interferon response in human cells. Infect Immun.1980;27:158–167.
- Wand M, Gilbert CM, Liesegang TJ. Latanoprost and herpes simplex keratitis. Am J Ophthalmol.1999;127: 602–604.
- Kaufman HE, Varnell ED, Thompson HIM Latanoprost increases the severity and recurrence of herpetic keratitis in the rabbit. Am J Ophthalmol.1999;127:531–536.
- O'Brien WJ, Taylor JL, Ankel H, Sitenga G. Assessment of antiviral activity, efficacy, and toxicity of prostaglandin A2 in a rabbit model of herpetic keratitis. Antimicrob Agents Chemother.1996;40:2327–2331.
- Inglot AD, Woyton A. Topical treatment of cutaneous herpes simplexin humans with the non-steroid antiinflam-matory drugs: mefenamic acid and indomethacin in dimethylsulfoxide. Arch Immunol Ther Exp.1971;19:555–566.
- Kurane I, Tsuchiya Y, Sekizawa T, Kumagai K. Inhibition by indomethacin of in vitroreactivation of latent herpes simplex virus type 1 in murine trigeminal ganglia. J Gen Virol.198465:1665-1674.
- Harbour DA, Hill TJ, Blyth WA. Acute and recurrent herpes simplex in several strains of mice. J Gen Virol.1981;55:31–40.
- Shimeld C, Hill TJ, Blyth WA, Easty DL. Reactivation of latent infection and induction of recurrent herpetic eye disease in mice. J Gen Virol.1990;71:397–404.
- Shimeld C, Easty DL, Hill TJ. Reactivation of herpes simplex virus type 1 in the mouse trigeminal ganglion: An in vivostudy of virus antigen and cytokines. J Virol.1999;73: 1767–1773.
- Minami M, Kita M, Yan X-Q, Yamamoto T, Iida T, Sekikawa K, Iwakura Y, Imanishi J. Role of IFN-y and tumor necrosis factor-a in herpes simplex type 1 infection. J Interfèron Cytokine Res.2002;22: 671–676.
- Athar M, An KP, Morel KD, Kim AL, Aszterbaum M, Longley J, Epstein EH Jr, Bickers DR. Ultraviolet B (UVB)-induced COX-2 expression in murine skin: An immunohistochemical study. Biochem Biophys Res Commun.2001;280:1042–1047.
- Hill JM, Lukiw WJ, Gebhardt BM, Higaki S, Loutsch JM, Myles ME, Thompson HW, Bazan NG, Kaufman HE. Gene expression analyzed by microarrays in HSV-1 latent mouse trigeminal ganglion following heat stress. Virus Genes.2001;23: 273–280.